Search results
Hims & Hers Is Now Selling Semaglutide: Here's What You Should Know
Verywell Health via Yahoo Finance· 3 hours agoThat makes them subject to state and federal oversight, Primack noted. However, this does not mean...
Small Business - The Brewton Standard | The Brewton Standard
The Brewton Standard· 8 hours agoFDA Roundup: May 21, 2024 PR Newswire SILVER SPRING, Md., May 21, 2024 SILVER SPRING, Md., May 21, 2024 /PRNewswire/ -- Today, the U.S. Food and Drug Administration is providing ...
FDA Approves Boehringer Ingelheim’s CYLTEZO® Biosimilar to Humira for Multiple Chronic Inflammatory...
JD Supra· 22 hours agoCYLTEZO was first approved in the US in 2017 and later approved in the US as an interchangeable biosimilar to Humira in October 2021. A lower concentration ...
Hims & Hers is selling an Ozempic knockoff without FDA approval. Here's how
Quartz· 10 hours agoThe millennial-skewed telehealth platform Hims & Hers this week joined several online pharmacies in...
FDA sets new review date for Halozyme's drug delivery tech By Investing.com
Investing.com· 12 hours agoHalozyme (NASDAQ:HALO) Therapeutics, Inc. (NASDAQ: HALO) announced that the U.S. Food and Drug...
US FDA staff says Guardant's test may fail to detect some pre-cancerous tumors
Reuters via Yahoo News· 15 hours agoThe reviewers, however, said the test may increase compliance with screening for colorectal cancer...
“The Good Doctor” series finale ends with moving goodbye to beloved character
Entertainment Weekly via Yahoo News· 2 hours agoShaun can't stop searching for a way to treat that either, but, with the help of others, he...
FDA grants approval for two Eylea biosimilars for eye conditions
Pharmaceutical Technology via Yahoo Finance· 20 hours agoThe US Food and Drug Administration (FDA) has approved Yesafili (aflibercept-jbvf) and Opuviz...
What's Going On With Colorectal Cancer Diagnostic-Focused Guardant Health Stock On Tuesday?
Benzinga via Yahoo Finance· 8 hours agoTuesday, the FDA's staff reviewers raised concerns regarding Guardant Health Inc's (NASDAQ:GH)...
Biocon Biologics Obtains U.S. FDA Approval for Biosimilar Aflibercept for Yesafili™. Enters U.S....
WTRF Wheeling· 17 hours agoFood and Drug Administration (US FDA) has approved the Company's first-to-file application for Yesafili™ (aflibercept-jbvf), an interchangeable* biosimilar ...